Skip to menu Skip to content Skip to footer

2008

Conference Publication

Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis

Crawford, D. H. G., Murphy, T. L., Ramm, L. E., Fletcher, L. M., Clouston, A. D., Anderson, G. J., Subramaniam, V. N., Powell, L. W. and Ramm, G. A. (2008). Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis. AGW 2008: Australian Gastroenterology Week 08, Brisbane, QLD, Australia, 22-25 October 2008. MALDEN: WILEY-BLACKWELL PUBLISHING, INC. doi: 10.1111/j.1440-1746.2008.05613.x

Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis

2008

Conference Publication

Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis

Crawford, Darrell H., Murphy, Therese L., Ramm, Louise E., Fletcher, Linda M., Clouston, Andrew D., Anderson, Gregory J., Subramaniam, V. Nathan, Powell, Lawrie W. and Ramm, Grant A. (2008). Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis. The Liver Meeting 2008: 59th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), San Francisco, CA, U.S.A., 31 October-4 November 2008. Hoboken, NJ, U.S.A.: John Wiley & Sons. doi: 10.1002/hep.22641

Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis

2008

Conference Publication

Multiple pathways to hepatic fibrosis are inhibited by rapamycin

Bridle, K. R., Sobbe, A. L., Fletcher, L. M., Clouston, A. D. and Crawford, D. H. G. (2008). Multiple pathways to hepatic fibrosis are inhibited by rapamycin. Australian Gastroenterology Week 2008, Brisbane, Qld, Australia, 22-25 October 2008. Carlton South, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2008.05613.x

Multiple pathways to hepatic fibrosis are inhibited by rapamycin

2008

Conference Publication

Rapamycin as an inhibitor of hepatic fibrosis: relevance to whole blood levels

Popa, C., Bridle, K. R., Morgan, M. L., Clouston, A. D., Fletcher, L. M. and Crawford, D. H. G. (2008). Rapamycin as an inhibitor of hepatic fibrosis: relevance to whole blood levels. 43rd Annual Meeting of the European Association for the Study of the Liver, Milan, Italy, 23-27 April, 2008. Ireland: Elsevier. doi: 10.1016/S0168-8278(08)60467-5

Rapamycin as an inhibitor of hepatic fibrosis: relevance to whole blood levels

2007

Conference Publication

Confocal endomicroscopy in the evaluation of celiac disease - A prospective validation study

Leong, Rupert W., Koo, Jenn H., Meredith, Christopher G., Clouston, Andrew D. and Merrett, Neil D. (2007). Confocal endomicroscopy in the evaluation of celiac disease - A prospective validation study. Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington Dc, May 19-24, 2007. NEW YORK: MOSBY-ELSEVIER. doi: 10.1016/j.gie.2007.03.829

Confocal endomicroscopy in the evaluation of celiac disease - A prospective validation study

2005

Conference Publication

TGF-beta in allogeneic stem cell transplantation: Friend or foe?

Banovic, T, MacDonald, K, Morris, E, Rowe, , Kuns, R, Don, A, Ledbetter, S, Clouston, A and Hill, G (2005). TGF-beta in allogeneic stem cell transplantation: Friend or foe?. 23rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, Canberra Australia, May 11-13, 2005. OXFORD: BLACKWELL PUBLISHING.

TGF-beta in allogeneic stem cell transplantation: Friend or foe?

2005

Conference Publication

TGF-beta and allogeneic stem cell transplantation: friend or foe?

Banovic, T, MacDonald, K, Morris, E, Rowe, , Kuns, R, Don, A, Ledbetter, S, Clouston, A and Hill, G (2005). TGF-beta and allogeneic stem cell transplantation: friend or foe?. 31st Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/21st Meeting of the EBMT-Nurses-Group/4th Meeting of the EBMT-Data-Management-Group, Prague Czech Republic, Mar 20-23, 2005. LONDON: NATURE PUBLISHING GROUP.

TGF-beta and allogeneic stem cell transplantation: friend or foe?

2005

Conference Publication

Hepatic progenitor cell expansion and a periportal ductular reaction in NAFLD - Relationship with impaired hepatocyte proliferation and fibrosis, and reversal with treatment

Richardson, M., Jonsson, J., Powell, E., Brunt, E. M., Bhathal, P., Dixon, J. and Clouston, A. (2005). Hepatic progenitor cell expansion and a periportal ductular reaction in NAFLD - Relationship with impaired hepatocyte proliferation and fibrosis, and reversal with treatment. 56th Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, CA, United States, 11-15 November 2005. HOBOKEN: JOHN WILEY & SONS INC.

Hepatic progenitor cell expansion and a periportal ductular reaction in NAFLD - Relationship with impaired hepatocyte proliferation and fibrosis, and reversal with treatment

2005

Conference Publication

Obesity is associated with non-response to antiviral therapy and increased hepatic expression of SOCS-3 in chronic hepatitis C

Walsh, M.J., Jonsson, J.R., Richardson, M.M., Lipka, G.M., Purdie, D.M., Clouston, A.D. and Powell, E.E. (2005). Obesity is associated with non-response to antiviral therapy and increased hepatic expression of SOCS-3 in chronic hepatitis C. 40th Annual Meeting of the European Association for the Study of the Liver, Paris, France, 13-17 April 2005. Amsterdam , Netherlands: Elsevier.

Obesity is associated with non-response to antiviral therapy and increased hepatic expression of SOCS-3 in chronic hepatitis C

2005

Conference Publication

Unexplained late centrilobular hepatitis after liver transplantation - Relationship to autoimmune hepatitis and GST-T1 mismatch

Clouston, A., Campbell, C., Lynch, S., Jonsson, J., Balderson, G., Barrie, H. and Crawford, D. (2005). Unexplained late centrilobular hepatitis after liver transplantation - Relationship to autoimmune hepatitis and GST-T1 mismatch. 56th Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, CA, United States, 11-15 November 2005. Hoboken, NJ, United States: John Wiley & Sons. doi: 10.1002/hep.20924

Unexplained late centrilobular hepatitis after liver transplantation - Relationship to autoimmune hepatitis and GST-T1 mismatch

2004

Conference Publication

Factors affecting the gene expression of hepcidin in chronic viral hepatitis C

Bridle, K. R., Fletcher, L. M., Jonsson, J. R., Richardson, M. M., Clouston, A. D., Powell, E. E. and Crawford, D. H. G. (2004). Factors affecting the gene expression of hepcidin in chronic viral hepatitis C. Australian Gastroenterology Week 2004, Brisbane Convention Centre, Brisbane, Qld Australia, 4-8 October, 2004. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2004.3615_3..x

Factors affecting the gene expression of hepcidin in chronic viral hepatitis C

2004

Conference Publication

Donor treatment with pegylated-G-CSF augments the generation of IL-10 producing regulatory T cells and promotes transplant tolerance

Morris, E., MacDonald, K., Rowe, V., Johnson, D., Banovic, T., Clouston, A. and Hill, G. (2004). Donor treatment with pegylated-G-CSF augments the generation of IL-10 producing regulatory T cells and promotes transplant tolerance. 22nd Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, Canberra, Australia, 31 March - 2 April 2004 . Basingstoke, U.K.: Nature Publishing Group.

Donor treatment with pegylated-G-CSF augments the generation of IL-10 producing regulatory T cells and promotes transplant tolerance

2003

Conference Publication

Donor treatment with peg-G-CSF induces profound transplant tolerance due to the generation of IL-10 producing regulatory T cells.

Morris, ES, MacDonald, KP, Rowe, V, Johnson, DH, Banovic, T, Clouston, AD and Hill, GR (2003). Donor treatment with peg-G-CSF induces profound transplant tolerance due to the generation of IL-10 producing regulatory T cells.. 45th Annual Meeting of the American-Society-of-Hematology, San Diego California, Dec 06-09, 2003. WASHINGTON: BLACKWELL PUBLISHING ASIA.

Donor treatment with peg-G-CSF induces profound transplant tolerance due to the generation of IL-10 producing regulatory T cells.

2003

Conference Publication

Absence of rejection after human liver orthotopic liver transplantation (OLT) is associated with leukocyte apoptosis, increased lymphocyte activation and higher donor cell chimerism

Clouston, A., Vanags, D. M., Gu, W. Y., Powell, E. E. and Jonsson, J. R. (2003). Absence of rejection after human liver orthotopic liver transplantation (OLT) is associated with leukocyte apoptosis, increased lymphocyte activation and higher donor cell chimerism. 55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease, Boston, MA, United States, 24-28 October 2003. Hoboken, NJ, United States: John Wiley & Sons.

Absence of rejection after human liver orthotopic liver transplantation (OLT) is associated with leukocyte apoptosis, increased lymphocyte activation and higher donor cell chimerism

2003

Conference Publication

Fibrosis in chronic hepatitis C is associated with hepatic progenitor cell proliferation and a periportal ductular reaction, which is exacerbated by steatosis: A new model for disease progression

Clouston, A. D., Jonsson, J. R., Letizia, B., Richardson, M. M., Vanags, D. M., Walsh, M., Demetris, A. J. and Powell, E. E. (2003). Fibrosis in chronic hepatitis C is associated with hepatic progenitor cell proliferation and a periportal ductular reaction, which is exacerbated by steatosis: A new model for disease progression. 55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease, Boston, MA, United States, 24-28 October 2003. Hoboken, NJ, United States: John Wiley & Sons.

Fibrosis in chronic hepatitis C is associated with hepatic progenitor cell proliferation and a periportal ductular reaction, which is exacerbated by steatosis: A new model for disease progression

2003

Conference Publication

Benefit of sustained weight loss and exercise in overweight patients with liver disease - Indicators for success

Hickman, I. J., Jonsson, J. R., Prins, J. B., Ash, S., Purdie, D. M., Clouston, A. D. and Powell, E. E. (2003). Benefit of sustained weight loss and exercise in overweight patients with liver disease - Indicators for success. 54th Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease, Boston, MA, United States, 24-28 October 2003. Hoboken, NJ, United States: John Wiley & Sons. doi: 10.1002/hep.1840380507

Benefit of sustained weight loss and exercise in overweight patients with liver disease - Indicators for success

2002

Conference Publication

Comparison of cell phenotypes shown by endemic liver fluke-associated and sporadic cholangiocarcinoma.

Bhathal, PS, Hughes, NR, Pairojkul, C, Royce, SG and Clouston, AD (2002). Comparison of cell phenotypes shown by endemic liver fluke-associated and sporadic cholangiocarcinoma.. 53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), Boston Massachusetts, Nov 01-05, 2002. PHILADELPHIA: W B SAUNDERS CO.

Comparison of cell phenotypes shown by endemic liver fluke-associated and sporadic cholangiocarcinoma.

2002

Conference Publication

Fibrosis in chronic hepatitis C correlates significantly with circulating C-peptide and insulin levels

Jonsson, J. R., Hickman, I. J., Clouston, A. D., Ash, S., Prins, J., Pandaya, N., Purdie, D. M. and Powell, E. E. (2002). Fibrosis in chronic hepatitis C correlates significantly with circulating C-peptide and insulin levels. 53rd Annual Meeting of the Association for the Study of Liver-Diseases (AASLD), Boston, M.A. USA, 01-05 November 2002. Hoboken, NJ United States: John Wiley and Sons.

Fibrosis in chronic hepatitis C correlates significantly with circulating C-peptide and insulin levels

2002

Conference Publication

Weight reduction improves biochemistry and histology in patients with chronic hepatitis C

Hickman, Ingrid, Clouston, Andrew, Ash, Susan, MacDonald, Graeme, Jonsson, Julie and Powell, Elizabeth (2002). Weight reduction improves biochemistry and histology in patients with chronic hepatitis C. Nutrition Week: A Scientific and Clinical Forum and Exposition, Bethesda, MD, 2002. Bethesda, MD: American Society for Nutrition.

Weight reduction improves biochemistry and histology in patients with chronic hepatitis C

2002

Conference Publication

Centrilobular hepatitis with elevated autoantibody titers after liver transplantation: autoimmune hepatitis or a form of rejection?

Clouston, A.D., McCullen, M., Fawcett, J. and Crawford, D.H. (2002). Centrilobular hepatitis with elevated autoantibody titers after liver transplantation: autoimmune hepatitis or a form of rejection?. 53rd Annual Meeting of the Association for the Study of Liver Diseases (AASLD), Boston, MA, United States, 1-5 November 2002. Hoboken, NJ, United States: John Wiley & Sons.

Centrilobular hepatitis with elevated autoantibody titers after liver transplantation: autoimmune hepatitis or a form of rejection?